Continuous Improvement and the Expansion of Quality ... - NCQA

Recommendations

Info

T H E S TAT E o f H E A l T H C A R E Q U A l I T y 2 0 1 1 • H E D I S M E A S U R E S o f C A R E • Discussing Cessation Strategies. A rolling average represents the percentage of adults 18 years of age and older who are current smokers or tobacco users who discussed or were provided cessation methods or strategies by a physician during the measurement year. results Care providers play an important role in supporting smokers’ efforts to quit. Smoking cessation practices are among the most advantageous methods for reducing smokingrelated deaths and health care costs. 2 yEAR advIsIng sMokErs and tobaCCo usErs to QuIt CoMMERCIAl MEDICARE MEDICAID HMo PPo HMo PPo HMo 2010 76.7 71.7 NA NA 73.6 2009 NA NA 77.9 75.2 NA 2008 76.7 71.6 76.9 76.5 69.3 2007 75.8 71.0 75.8 75.4 69.4 2006 73.8 70.1 76.1 77.3 68.2 2005 71.2 66.9 75.5 77.3 65.6 2004 69.6 NA 64.7 NA 66.7 2003 68.6 NA 62.9 NA 65.8 2002 67.7 NA 61.6 NA 63.6 2001 65.7 NA 60.9 NA 63.9 2000 66.3 NA NA NA NA yEAR dIsCussIng CEssatIon stratEgIEs CoMMERCIAl MEDICARE MEDICAID HMo PPo HMo PPo HMo 2010 45.0 39.0 NA NA 38.5 2008 49.7 43.3 NA NA 40.8 2007 48.0 44.2 NA NA 39.2 2006 43.2 42.6 NA NA 36.7 2005 38.9 35.1 NA NA 33.9 2004 36.8 NA NA NA 32.7 2003 36.0 NA NA NA 32.3 yEAR dIsCussIng CEssatIon MEdICatIons 47 CoMMERCIAl MEDICARE MEDICAID HMo PPo HMo PPo HMo 2010 52.4 47.2 NA NA 42.7 2008 54.4 50.9 NA NA 40.6 2007 50.9 49.6 NA NA 38.7 2006 43.9 43.8 NA NA 35.1 2005 39.4 36.7 NA NA 31.8 2004 37.8 NA NA NA 31.3 2003 37.6 NA NA NA 31.5 W E l l N E S S A N D P R E V E N T I o N
C H R o N I C D I S E A S E M A N A G E M E N T 48 N AT I o N A l C o M M I T T E E f o R Q U A l I T y A S S U R A N C E PERSISTENCE of bETA-bloCkER TREATMENT AfTER A HEART ATTACk Heart attacks occur when blood clots obscure the main blood vessel that feeds the heart. loss of blood flow may permanently damage the heart tissue. 1 Each year, an estimated 785,000 Americans suffer a heart attack. of these, 470,000 have had at least one heart attack before, and 150,000 are under the age of 65. 2,3 The Persistence of Beta-Blocker Treatment After a Heart Attack measure reports the number of people who had a heart attack and received beta-blocker treatment during the six months following their discharge from the hospital. • beta-blocker therapy has been shown to reduce mortality when used after a heart attack. 4 These drugs can also reduce patients’ risk for hospital readmission in the first year. 5 • beta-blocker therapy restores blood flow, which reduces damage to the heart muscle. beta-blockers slow heart rate, lower blood pressure and prevent irregular heartbeats by blocking nervous impulses or stress responses to the heart. 6,7 the Case for Improvement • Despite beta-blockers’ effectiveness, adherence to beta-blocker therapy is poor. only 45 percent of patients consistently took their medications in the first year after discharge. 8 lack of adherence has been shown to increase patients’ risk of dying. 9 • If beta-blocker adherence could be increased to 100 percent in first-time heart attack survivors for 20 years, an estimated 62,000 heart attacks would be prevented, 72,000 deaths from coronary heart disease avoided, 447,000 life-years gained and $18 million saved. 10,11 • Although the elderly benefit from betablocker therapy, many patients are not prescribed these medications. of all adults who are good candidates for beta-blocker medication, only 43.8 percent of nursing home residents and 61.4 percent of community-dwelling residents receive betablockers. Research has shown that mortality is significantly lower for nursing home patients who receive beta-blockers. 12
Page 1 and 2: Continuous Improvement and the Expa
Page 3 and 4: 2 This Report and the data containe
Page 5 and 6: 4 N AT I o N A l C o M M I T T E E
Page 13 and 14: top 10 and bottom 10 states “loca
Page 17 and 18: 16 this measure has shown steady ga
Page 25 and 26: 24 HEDIS MEASURES of CARE about HEd
Page 27 and 28: S A f E T y A N D P o T E N T I A l
Page 37 and 38: W E l l N E S S A N D P R E V E N T
Page 47: W E l l N E S S A N D P R E V E N T
Page 51 and 52: C H R o N I C D I S E A S E M A N A
Page 73 and 74: M E A S U R E S T A R G E T E D A T
Page 99 and 100:
M E A S U R E S T A R G E T E D A T
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
C o N S U M E R A N D P A T I E N T
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
128 N AT I o N A l C o M M I T T E
Page 131 and 132:
130 APPENDIx 1: HEDIS EffECTIVENESS
Page 133 and 134:
Page 135 and 136:
134 APPENDIx 2: HEDIS EffECTIVENESS
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
142 APPENDIx 4b: ACCREDITED VS. NoN
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
148 APPENDIx 6A: ACCREDITED VS. NoN
Page 151 and 152:
150 APPENDIx 6b: ACCREDITED VS. NoN
Page 153 and 154:
152 APPENDIx 7A: PUblICly REPoRTING
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
158 APPENDIx 8: PUblICly REPoRTING
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
172 MEASURE N AT I o N A l C o M M
Page 175 and 176:
174 APPENDIx 14b: VARIATIoN IN PlAN
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
180 APPENDIx 16A: VARIATIoN IN PlAN
Page 183 and 184:
182 APPENDIx 16b: VARIATIoN IN PlAN
Page 185 and 186:
184 REfERENCES N AT I o N A l C o M
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 200 and 201:
ACkNoWlEDGMENTS Health Plans The 20
show all

Continuous Improvement and the Expansion of Quality ... - NCQA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?